|
1
|
Yadouleton A, Nouatin O, Kissira I, Houngbegnon P, Cottrell G, Fievet N, Sohou S, Butel C, Serrano L, Guichet E, Vidal N, Delaporte E, Ayouba A, Peeters M, Massougbodji A. Genomic surveillance of dengue virus in Benin. INFECTION, GENETICS AND EVOLUTION : JOURNAL OF MOLECULAR EPIDEMIOLOGY AND EVOLUTIONARY GENETICS IN INFECTIOUS DISEASES 2024; 125:105674. [PMID: 39342977 DOI: 10.1016/j.meegid.2024.105674] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/24/2024] [Revised: 09/22/2024] [Accepted: 09/25/2024] [Indexed: 10/01/2024]
Abstract
OBJECTIVE Dengue is a widespread viral infection transmitted from mosquitoes to humans, mainly in tropical and subtropical climates. In Benin, only dengue virus (DENV) serotype 2 infection has been previously described in humans. This study aimed to investigate DENV infection and serotypes in suspected patients. METHODS Plasma samples from 464 patients attending health centers in February 2023 with clinical symptoms and suspected for dengue infection were included, and analyzed for DENV by real time quantitative Polymerase Chain Reaction (Dengue Altona 3.0 kit). PCR positives samples were further characterized by whole genome sequencing and phylogenetic analysis to identify the circulating DENV serotype. RESULTS The RT-qPCR results showed that four patients (D6, D23, D28, D44) were positive with the cycle threshold values less than 40 (31.3, 34.7, 14.7 and 14.3) respectively. Full-length DENV sequences were obtained for D6, D28 and D44. One patient (D6) was infected with DENV-1 serotype, and the two others (D28 and D44) were positive for DENV-3. Phylogenetic analysis shows that the new DENV-1 sequence is close to those obtained in Burkina Faso in 2022 and Nigeria in 2023, and the two DENV-3 sequences form a separate cluster with sequences obtained in Burkina Faso in 2022. CONCLUSION We showed for the first time, the presence of dengue serotype 1 and serotype 3 infection in Benin. These results send a strong signal to health authorities and show that arbovirus surveillance efforts must be integrated into pathogen monitoring programs.
Collapse
Affiliation(s)
- Anges Yadouleton
- Laboratoire des fièvres hémorragiques virales du Bénin, Ministry of Health of Benin, 01-882 Cotonou, Bénin; Ecole Normale Supérieure de Natitingou, Université Nationale des Sciences Technologies, Ingénierie et Mathématiques, 2282, Goho, Abomey, Benin
| | - Odilon Nouatin
- Institut de Recherche Clinique du Bénin, Abomey-Calavi 04BP 1114, Benin.
| | - Islamiath Kissira
- Laboratoire des fièvres hémorragiques virales du Bénin, Ministry of Health of Benin, 01-882 Cotonou, Bénin; Ecole Normale Supérieure de Natitingou, Université Nationale des Sciences Technologies, Ingénierie et Mathématiques, 2282, Goho, Abomey, Benin; Institut de Recherche Clinique du Bénin, Abomey-Calavi 04BP 1114, Benin
| | | | - Gilles Cottrell
- Université de Paris Cité, Institut de Recherche pour le Développement, MERIT, Paris, France
| | - Nadine Fievet
- Université de Paris Cité, Institut de Recherche pour le Développement, MERIT, Paris, France
| | - Stephane Sohou
- Laboratoire des fièvres hémorragiques virales du Bénin, Ministry of Health of Benin, 01-882 Cotonou, Bénin
| | - Christelle Butel
- Recherches Translationnelles sur le VIH et les Maladies Infectieuses (TransVIHMI), University of Montpellier, INSERM, Institut de Recherche pour le Développement, Montpellier, France
| | - Laetitia Serrano
- Recherches Translationnelles sur le VIH et les Maladies Infectieuses (TransVIHMI), University of Montpellier, INSERM, Institut de Recherche pour le Développement, Montpellier, France
| | - Emilande Guichet
- Recherches Translationnelles sur le VIH et les Maladies Infectieuses (TransVIHMI), University of Montpellier, INSERM, Institut de Recherche pour le Développement, Montpellier, France
| | - Nicole Vidal
- Recherches Translationnelles sur le VIH et les Maladies Infectieuses (TransVIHMI), University of Montpellier, INSERM, Institut de Recherche pour le Développement, Montpellier, France
| | - Eric Delaporte
- Recherches Translationnelles sur le VIH et les Maladies Infectieuses (TransVIHMI), University of Montpellier, INSERM, Institut de Recherche pour le Développement, Montpellier, France
| | - Ahidjo Ayouba
- Recherches Translationnelles sur le VIH et les Maladies Infectieuses (TransVIHMI), University of Montpellier, INSERM, Institut de Recherche pour le Développement, Montpellier, France
| | - Martine Peeters
- Recherches Translationnelles sur le VIH et les Maladies Infectieuses (TransVIHMI), University of Montpellier, INSERM, Institut de Recherche pour le Développement, Montpellier, France
| | | |
Collapse
|
|
2
|
Tsegaye MM, Mekonnen AT, Gebretsion DT, Gelanew T, Alemayehu DH, Tefera DA, Woldemichael TS, Getaneh BA, Abera EK, Jebessa GG, Korkiso AK, Tessema MB, Asfaw AA, Temre YA, Wossen M, Piantadosi A, Zhu H, Abdissa A, Mihret A, Mulu A. Predominance of Dengue Virus Serotype-1/Genotype-I in Eastern and Southeastern Ethiopia. Viruses 2024; 16:1334. [PMID: 39205308 PMCID: PMC11359325 DOI: 10.3390/v16081334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2024] [Revised: 07/29/2024] [Accepted: 07/30/2024] [Indexed: 09/04/2024] Open
Abstract
We determined the dengue virus (DENV) serotypes and genotypes in archived serum samples that were collected during the 2014-2016 and 2021 dengue outbreaks in Dire Dawa City and the Somali region in Ethiopia. DENV serotype 1 (DENV-1) was predominant followed by DENV serotype 2 (DENV-2). Thirteen of the DENV-1 strains were assigned to Genotype-I, while the remaining two were found to be Genotype-III. All three DENV-2 strains were assigned the Cosmopolitan Genotype. The DENV strains responsible for the outbreaks are genetically closely related to the DENV strains that circulated in neighboring and Asian countries. The findings also showed continued local transmission of a monophyletic lineage and a co-circulation of DENV-1 and DENV-2 during the outbreaks. There is a need to strengthen DENV genomic surveillance capacity for the early detection of circulating serotypes, and prevent devastating consequences of future outbreaks due to the co-circulation of different serotypes.
Collapse
Affiliation(s)
- Mesfin Mengesha Tsegaye
- Viral Diseases Research Division, Armauer Hansen Research Institute, Addis Ababa P.O. Box 1005, Ethiopia; (T.G.); (D.H.A.); (D.A.T.); (T.S.W.); (B.A.G.); (A.A.); (A.M.); (A.M.)
- State Key Laboratory of Emerging Infectious Diseases, School of Public Health, The University of Hong Kong, Hong Kong SAR 999077, China;
| | - Adamu Tayachew Mekonnen
- Public Health Emergency Management Center, Ethiopian Public Health Institute, Addis Ababa P.O. Box 1242, Ethiopia; (A.T.M.); (D.T.G.); (E.K.A.); (G.G.J.); (A.K.K.); (M.B.T.); (A.A.A.); (Y.A.T.); (M.W.)
| | - Daniel Tsega Gebretsion
- Public Health Emergency Management Center, Ethiopian Public Health Institute, Addis Ababa P.O. Box 1242, Ethiopia; (A.T.M.); (D.T.G.); (E.K.A.); (G.G.J.); (A.K.K.); (M.B.T.); (A.A.A.); (Y.A.T.); (M.W.)
| | - Tesfaye Gelanew
- Viral Diseases Research Division, Armauer Hansen Research Institute, Addis Ababa P.O. Box 1005, Ethiopia; (T.G.); (D.H.A.); (D.A.T.); (T.S.W.); (B.A.G.); (A.A.); (A.M.); (A.M.)
| | - Dawit Hailu Alemayehu
- Viral Diseases Research Division, Armauer Hansen Research Institute, Addis Ababa P.O. Box 1005, Ethiopia; (T.G.); (D.H.A.); (D.A.T.); (T.S.W.); (B.A.G.); (A.A.); (A.M.); (A.M.)
| | - Dessalegn Abeje Tefera
- Viral Diseases Research Division, Armauer Hansen Research Institute, Addis Ababa P.O. Box 1005, Ethiopia; (T.G.); (D.H.A.); (D.A.T.); (T.S.W.); (B.A.G.); (A.A.); (A.M.); (A.M.)
| | - Tamirayehu Seyoum Woldemichael
- Viral Diseases Research Division, Armauer Hansen Research Institute, Addis Ababa P.O. Box 1005, Ethiopia; (T.G.); (D.H.A.); (D.A.T.); (T.S.W.); (B.A.G.); (A.A.); (A.M.); (A.M.)
| | - Bethlehem Adnew Getaneh
- Viral Diseases Research Division, Armauer Hansen Research Institute, Addis Ababa P.O. Box 1005, Ethiopia; (T.G.); (D.H.A.); (D.A.T.); (T.S.W.); (B.A.G.); (A.A.); (A.M.); (A.M.)
| | - Eleni Kidane Abera
- Public Health Emergency Management Center, Ethiopian Public Health Institute, Addis Ababa P.O. Box 1242, Ethiopia; (A.T.M.); (D.T.G.); (E.K.A.); (G.G.J.); (A.K.K.); (M.B.T.); (A.A.A.); (Y.A.T.); (M.W.)
| | - Gadissa Gutema Jebessa
- Public Health Emergency Management Center, Ethiopian Public Health Institute, Addis Ababa P.O. Box 1242, Ethiopia; (A.T.M.); (D.T.G.); (E.K.A.); (G.G.J.); (A.K.K.); (M.B.T.); (A.A.A.); (Y.A.T.); (M.W.)
| | - Asefa Konde Korkiso
- Public Health Emergency Management Center, Ethiopian Public Health Institute, Addis Ababa P.O. Box 1242, Ethiopia; (A.T.M.); (D.T.G.); (E.K.A.); (G.G.J.); (A.K.K.); (M.B.T.); (A.A.A.); (Y.A.T.); (M.W.)
| | - Mengistu Biru Tessema
- Public Health Emergency Management Center, Ethiopian Public Health Institute, Addis Ababa P.O. Box 1242, Ethiopia; (A.T.M.); (D.T.G.); (E.K.A.); (G.G.J.); (A.K.K.); (M.B.T.); (A.A.A.); (Y.A.T.); (M.W.)
| | - Admikew Agunie Asfaw
- Public Health Emergency Management Center, Ethiopian Public Health Institute, Addis Ababa P.O. Box 1242, Ethiopia; (A.T.M.); (D.T.G.); (E.K.A.); (G.G.J.); (A.K.K.); (M.B.T.); (A.A.A.); (Y.A.T.); (M.W.)
| | - Yoseph Asrat Temre
- Public Health Emergency Management Center, Ethiopian Public Health Institute, Addis Ababa P.O. Box 1242, Ethiopia; (A.T.M.); (D.T.G.); (E.K.A.); (G.G.J.); (A.K.K.); (M.B.T.); (A.A.A.); (Y.A.T.); (M.W.)
| | - Mesfin Wossen
- Public Health Emergency Management Center, Ethiopian Public Health Institute, Addis Ababa P.O. Box 1242, Ethiopia; (A.T.M.); (D.T.G.); (E.K.A.); (G.G.J.); (A.K.K.); (M.B.T.); (A.A.A.); (Y.A.T.); (M.W.)
| | - Anne Piantadosi
- Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA;
| | - Huachen Zhu
- State Key Laboratory of Emerging Infectious Diseases, School of Public Health, The University of Hong Kong, Hong Kong SAR 999077, China;
| | - Alemseged Abdissa
- Viral Diseases Research Division, Armauer Hansen Research Institute, Addis Ababa P.O. Box 1005, Ethiopia; (T.G.); (D.H.A.); (D.A.T.); (T.S.W.); (B.A.G.); (A.A.); (A.M.); (A.M.)
| | - Adane Mihret
- Viral Diseases Research Division, Armauer Hansen Research Institute, Addis Ababa P.O. Box 1005, Ethiopia; (T.G.); (D.H.A.); (D.A.T.); (T.S.W.); (B.A.G.); (A.A.); (A.M.); (A.M.)
| | - Andargachew Mulu
- Viral Diseases Research Division, Armauer Hansen Research Institute, Addis Ababa P.O. Box 1005, Ethiopia; (T.G.); (D.H.A.); (D.A.T.); (T.S.W.); (B.A.G.); (A.A.); (A.M.); (A.M.)
| |
Collapse
|
|
3
|
Nigussie E, Atlaw D, Negash G, Gezahegn H, Baressa G, Tasew A, Zembaba D. A dengue virus infection in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis 2024; 24:297. [PMID: 38448847 PMCID: PMC10918862 DOI: 10.1186/s12879-024-09142-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2023] [Accepted: 02/14/2024] [Indexed: 03/08/2024] Open
Abstract
BACKGROUND Dengue is caused by a positive-stranded RNA virus called dengue virus, which is spread by Aedes mosquito species. It is a fast-growing acute febrile disease with potentially lethal consequences that is a global public health problem, mostly in tropical and subtropical countries. In Ethiopia, dengue fever is understudied, although the virus is still being transmitted and viral infection rates are rising. This systematic review and meta-analysis was aimed at estimating the pooled prevalence of DENV infection in Ethiopia. METHODS A literature search was done on the PubMed, Hinari and Google Scholar databases to identify studies published before July, 2023. Random effects and fixed effects models were used to estimate the pooled prevalence of all three markers. The Inconsistency Index was used to assess the level of heterogeneity. RESULTS A total of 11 studies conducted on suspected individuals with dengue fever and acutely febrile participants were included in this review. The majority of the studies had a moderate risk of bias and no study had a high risk of bias. A meta-analysis estimated a pooled IgG prevalence of 21% (95% CI: 19-23), a pooled IgM prevalence of 9% (95%CI: 4-13) and a pooled DENV-RNA prevalence of 48% (95% CI: 33-62). There is evidence of possible publication bias in IgG but not in the rest of the markers. CONCLUSION Dengue is prevalent among the dengue fever suspected and febrile population in Ethiopia. Healthcare providers, researchers and policymakers should give more attention to dengue fever.
Collapse
Affiliation(s)
- Eshetu Nigussie
- Department of Medical Laboratory Science, School of Medicine, Madda Walabu University, Addis Ababa, Ethiopia.
| | - Daniel Atlaw
- Department of Biomedical Science, School of Medicine, Madda Walabu University, Addis Ababa, Ethiopia
| | - Getahun Negash
- Department of Medical Laboratory Science, School of Medicine, Madda Walabu University, Addis Ababa, Ethiopia
| | - Habtamu Gezahegn
- Department of Biomedical Science, School of Medicine, Madda Walabu University, Addis Ababa, Ethiopia
| | - Girma Baressa
- Department of Public Health, School of Health Science, Madda Walabu University, Addis Ababa, Ethiopia
| | - Alelign Tasew
- Department of Public Health, School of Health Science, Madda Walabu University, Addis Ababa, Ethiopia
| | - Demisu Zembaba
- Department of Public Health, School of Health Science, Madda Walabu University, Addis Ababa, Ethiopia
| |
Collapse
|
|
4
|
Vicco A, McCormack CP, Pedrique B, Amuasi JH, Awuah AAA, Obirikorang C, Struck NS, Lorenz E, May J, Ribeiro I, Malavige GN, Donnelly CA, Dorigatti I. A simulation-based method to inform serosurvey design for estimating the force of infection using existing blood samples. PLoS Comput Biol 2023; 19:e1011666. [PMID: 38011203 PMCID: PMC10727435 DOI: 10.1371/journal.pcbi.1011666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2023] [Revised: 12/18/2023] [Accepted: 11/06/2023] [Indexed: 11/29/2023] Open
Abstract
The extent to which dengue virus has been circulating globally and especially in Africa is largely unknown. Testing available blood samples from previous cross-sectional serological surveys offers a convenient strategy to investigate past dengue infections, as such serosurveys provide the ideal data to reconstruct the age-dependent immunity profile of the population and to estimate the average per-capita annual risk of infection: the force of infection (FOI), which is a fundamental measure of transmission intensity. In this study, we present a novel methodological approach to inform the size and age distribution of blood samples to test when samples are acquired from previous surveys. The method was used to inform SERODEN, a dengue seroprevalence survey which is currently being conducted in Ghana among other countries utilizing samples previously collected for a SARS-CoV-2 serosurvey. The method described in this paper can be employed to determine sample sizes and testing strategies for different diseases and transmission settings.
Collapse
Affiliation(s)
- Anna Vicco
- Department of Molecular Medicine, University of Padua, Padua, Italy
- MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom
| | - Clare P. McCormack
- MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom
| | - Belen Pedrique
- Drugs for Neglected Diseases initiative, Geneva, Switzerland
| | - John H. Amuasi
- Department of Global Health, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
- Global Health and Infectious Diseases Research Group, Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana
- Research Group Global One Health, Department of Implementation Research, Bernhard Nocht Institute of Tropical Medicine, Hamburg, Germany
- Division for Tropical Medicine, Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | - Anthony Afum-Adjei Awuah
- Global Health and Infectious Diseases Research Group, Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana
- Research Group Global One Health, Department of Implementation Research, Bernhard Nocht Institute of Tropical Medicine, Hamburg, Germany
- Department of Molecular Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
| | - Christian Obirikorang
- Global Health and Infectious Diseases Research Group, Kumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana
- Research Group Global One Health, Department of Implementation Research, Bernhard Nocht Institute of Tropical Medicine, Hamburg, Germany
- Department of Molecular Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
| | - Nicole S. Struck
- Infectious Disease Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
- German Center for Infection Research (DZIF), partner site Hamburg-Borstel-Lübeck-Riems, Germany
| | - Eva Lorenz
- Infectious Disease Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
- German Center for Infection Research (DZIF), partner site Hamburg-Borstel-Lübeck-Riems, Germany
- Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany
| | - Jürgen May
- Infectious Disease Epidemiology, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany
- German Center for Infection Research (DZIF), partner site Hamburg-Borstel-Lübeck-Riems, Germany
- Department of Tropical Medicine I, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - Isabela Ribeiro
- Drugs for Neglected Diseases initiative, Geneva, Switzerland
| | | | - Christl A. Donnelly
- MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom
- Department of Statistics, University of Oxford, Oxford, United Kingdom
- Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom
| | - Ilaria Dorigatti
- MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom
| |
Collapse
|
|
5
|
Kayange N, Hau DK, Pain K, Mshana SE, Peck R, Gehring S, Groendahl B, Koliopoulos P, Revocatus B, Msaki EB, Malande O. Seroprevalence of Dengue and Chikungunya Virus Infections in Children Living in Sub-Saharan Africa: Systematic Review and Meta-Analysis. CHILDREN (BASEL, SWITZERLAND) 2023; 10:1662. [PMID: 37892325 PMCID: PMC10605353 DOI: 10.3390/children10101662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/26/2023] [Revised: 09/23/2023] [Accepted: 09/28/2023] [Indexed: 10/29/2023]
Abstract
Dengue and chikungunya viruses are frequent causes of malarial-like febrile illness in children. The rapid increase in virus transmission by mosquitoes is a global health concern. This is the first systematic review and meta-analysis of the childhood prevalence of dengue and chikungunya in Sub-Saharan Africa (SSA). A comprehensive search of the MEDLINE (Ovid), Embase (Ovid), and Cochrane Library (Wiley) databases was conducted on 28 June 2019, and updated on 12 February 2022. The search strategy was designed to retrieve all articles pertaining to arboviruses in SSA children using both controlled vocabulary and keywords. The pooled (weighted) proportion of dengue and chikungunya was estimated using a random effect model. The overall pooled prevalence of dengue and chikungunya in SSA children was estimated to be 16% and 7%, respectively. Prevalence was slightly lower during the period 2010-2020 compared to 2000-2009. The study design varied depending on the healthcare facility reporting the disease outbreak. Importantly, laboratory methods used to detect arbovirus infections differed. The present review documents the prevalence of dengue and chikungunya in pediatric patients throughout SSA. The results provide unprecedented insight into the transmission of dengue and chikungunya viruses among these children and highlight the need for enhanced surveillance and controlled methodology.
Collapse
Affiliation(s)
- Neema Kayange
- Department of Pediatrics, Bugando Medical Centre, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza P.O. Box 1464, Tanzania;
| | - Duncan K Hau
- Department of Pediatrics, Weill Cornell Medical College, New York, NY 10065, USA;
| | - Kevin Pain
- Samuel J. Wood Library and C.V. Starr Biomedical Information Center, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA;
| | - Stephen E Mshana
- Department of Microbiology and Immunology, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza P.O. Box 1464, Tanzania;
| | - Robert Peck
- Department of Pediatrics, Bugando Medical Centre, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza P.O. Box 1464, Tanzania;
- Department of Pediatrics, Weill Cornell Medical College, New York, NY 10065, USA;
- Center for Global Health, Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA
| | - Stephan Gehring
- Department of Pediatrics, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany; (S.G.); (B.G.); (P.K.)
| | - Britta Groendahl
- Department of Pediatrics, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany; (S.G.); (B.G.); (P.K.)
| | - Philip Koliopoulos
- Department of Pediatrics, University Medical Center of the Johannes Gutenberg University, 55131 Mainz, Germany; (S.G.); (B.G.); (P.K.)
| | - Baraka Revocatus
- Department of Data and Statistics, Bugando Medical Centre, Mwanza P.O. Box 1370, Tanzania;
| | - Evarist B Msaki
- Department of Epidemiology and Biostatistics, Bugando Medical Centre, Mwanza P.O. Box 1370, Tanzania;
| | - Ombeva Malande
- East Africa Centre for Vaccines and Immunization (ECAVI), Kampala P.O. Box 3040, Uganda;
- Department of Public Health Phamarmacy, Sefako Makgatho Health Sciences University, Pretoria P.O. Box 60, South Africa
- Department of Paediatrics & Child Health, Makerere University, Kampala P.O. Box 7072, Uganda
- Department of Public Health, UNICAF University, Lusaka P.O. Box 20842, Zambia
| |
Collapse
|
|
6
|
Akbar SMF, Khan S, Mahtab M, Mahtab MA, Yahiro T, Arafat SM, Sarker MAS, Podder PK, Hossain MS, Khandokar FA, Hassan MR, Rahim MA, Ashraf MA, Rony RS, Nishizono A. Recent Dengue Infection in Bangladesh: A Seasonal Endemic Progressing to Year-long Serious Health Concern. Euroasian J Hepatogastroenterol 2023; 13:145-151. [PMID: 38222961 PMCID: PMC10785144 DOI: 10.5005/jp-journals-10018-1408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/02/2023] [Accepted: 11/04/2023] [Indexed: 01/16/2024] Open
Abstract
Dengue represents one of the most dangerous mosquito-borne viral diseases. Although the disease has been prevalent around the globe over the centuries, recent outbreaks of dengue have devasted the healthcare delivery system of many countries. Being a global infection, dengue virus (DENV) is endemically present mainly in Latin America and Caribbean countries as well as countries in South Asia. The recent outbreak of DENV infection has indicated an exceptional outbreak of DENV in some countries in South Asia. There has been a serious endemic of DENV during 2019. After a heterogeneous pause, another severe outbreak of DENV was reported in some Asian countries in 2023. Among the Asian countries, Bangladesh has reported an acute upsurge of DENV infection in 2023 with record numbers of fatalities. However, this pattern of DENV has not been detected in neighbors of Bangladesh, such as India or other countries in Southeast Asia. This provides an emergent task of dissecting the present DENV infection in Bangladesh from different angles to get insights for future containment of the DENV infection, not only in Bangladesh but also in other DENV endemic areas or DENV-native areas. How to cite this article Akbar SMF, Khan S, Mahtab M, et al. Recent Dengue Infection in Bangladesh: A Seasonal Endemic Progressing to Year-long Serious Health Concern. Euroasian J Hepato-Gastroenterol 2023;13(2):145-151.
Collapse
Affiliation(s)
- Sheikh Mohammad Fazle Akbar
- Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine; Research Center for Global and Local Infectious Diseases, Faculty of Medicine, Oita University, Oita, Japan; Miyakawa Memorial Research Foundation, Tokyo, Japan
| | - Sakirul Khan
- Research Center for Global and Local Infectious Diseases; Department of Microbiology, Faculty of Medicine, Oita University, Oita, Japan
| | - Musarrat Mahtab
- Department of Biochemistry and Biotechnology, North South University, Dhaka, Bangladesh
| | - Mamun Al Mahtab
- Interventional Hepatology Division, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
| | - Takaaki Yahiro
- Research Center for Global and Local Infectious Diseases; Department of Microbiology; Department of Advanced Medical Sciences, Faculty of Medicine, Oita University, Oita, Japan
| | - Shohael Mahmud Arafat
- Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
| | | | | | | | | | | | - Md Abdur Rahim
- Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
| | - Muhammad Ali Ashraf
- Acute Medicine Unit, Sir Salimullah Medical, College Mitford Hospital, Dhaka, Bangladesh
| | - Rajib Saha Rony
- Department of Hepatology, Sir Salimullah Medical College, Dhaka, Bangladesh
| | - Akira Nishizono
- Research Center for Global and Local Infectious Diseases; Department of Microbiology, Faculty of Medicine, Oita University, Oita, Japan
| |
Collapse
|
|
7
|
Massengo NRB, Tinto B, Simonin Y. One Health Approach to Arbovirus Control in Africa: Interests, Challenges, and Difficulties. Microorganisms 2023; 11:1496. [PMID: 37374998 PMCID: PMC10302248 DOI: 10.3390/microorganisms11061496] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Revised: 05/25/2023] [Accepted: 06/04/2023] [Indexed: 06/29/2023] Open
Abstract
The "One Health" concept considers that human and animal health, and ecosystems are closely related and aims to make a link between ecology and human and veterinary medicine. Due to the explosion in population growth along with the geographic and climatic conditions (equatorial and/or tropical climate), Africa is becoming a major hotspot for various socio-health issues associated with infectious diseases, including arboviruses. The incontestable advantages of a One Health approach in Africa lie in the fight against pathogens, such as arboviruses, and in the preservation of environmental, animal, and human health to ensure that the increasing high needs of this population are met as well as their protection against potential epidemics. The One Health strategy gives us a glimpse of the difficulties and challenges that the African continent faces. The importance of this approach in Africa is to establish guidelines and strategies for effective solutions and changes in behavior and harmful activities. Overall, the establishment of high-quality global health policies in the framework of the global health standards program would provide healthy and sustainable human-animal-environmental interactions for the welfare of all.
Collapse
Affiliation(s)
- Norvi Rigobert Bienvenu Massengo
- Formation Doctorale de Santé et Biologie Humaine, Faculté des Sciences de la Santé, Université Marien NGOUABI, Brazzaville BP69, Congo
| | - Bachirou Tinto
- Centre MURAZ, Institut National de Santé Publique (INSP), Bobo-Dioulasso 01, Burkina Faso;
| | - Yannick Simonin
- Pathogenesis and Control of Chronic and Emerging Infections, INSERM, University of Montpellier, Etablissement Français du Sang, 34394 Montpellier, France
| |
Collapse
|
|
8
|
Canelas T, Thomsen E, Kamgang B, Kelly‐Hope LA. Demographic and environmental factors associated with the distribution of Aedes albopictus in Cameroon. MEDICAL AND VETERINARY ENTOMOLOGY 2023; 37:143-151. [PMID: 36264191 PMCID: PMC10092813 DOI: 10.1111/mve.12619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Accepted: 09/26/2022] [Indexed: 06/16/2023]
Abstract
Aedes-transmitted arboviruses have spread globally due to the spread of Aedes aegypti and Aedes albopictus. Its distribution is associated with human and physical geography. However, these factors have not been quantified in Cameroon. Therefore, the aim was to develop an Ae. albopictus geo-referenced database to examine the risk factors associated with the vector distribution in Cameroon. Data on the Ae. albopictus presence and absence were collated and mapped from studies in published scientific literature between 2000 and 2020. Publicly available earth observation data were used to assess human geography, land use and climate risk factors related to the vector distribution. A logistic binomial regression was conducted to identify the significant risk factors associated with Ae. albopictus distribution. In total, 111 data points were collated (presence = 87; absence = 24). Different data collection methods and sites hindered the spatiotemporal analysis. An increase of one wet month in a year increased the odds of Ae. albopictus presence by 5.6 times. One unit of peri-urban area increased the odds by 1.3 times. Using publicly available demographic and environmental data to better understand the key determinants of mosquito distributions may facilitate appropriately targeted public health messages and vector control strategies.
Collapse
Affiliation(s)
- Tiago Canelas
- Department of Vector BiologyLiverpool School of Tropical MedicineLiverpoolUK
- Medical Research Council Epidemiology UnitUniversity of CambridgeCambridgeUK
| | - Edward Thomsen
- Department of Vector BiologyLiverpool School of Tropical MedicineLiverpoolUK
| | - Basile Kamgang
- Department of Medical EntomologyCentre for Research in Infectious DiseasesYaoundéCameroon
| | - Louise A. Kelly‐Hope
- Department of Livestock and One HealthInstitute of Infection, Veterinary and Ecological Sciences, University of LiverpoolLiverpoolUK
| |
Collapse
|
|
9
|
Okoro OJ, Deme GG, Okoye CO, Eze SC, Odii EC, Gbadegesin JT, Okeke ES, Oyejobi GK, Nyaruaba R, Ebido CC. Understanding key vectors and vector-borne diseases associated with freshwater ecosystem across Africa: Implications for public health. THE SCIENCE OF THE TOTAL ENVIRONMENT 2023; 862:160732. [PMID: 36509277 DOI: 10.1016/j.scitotenv.2022.160732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/04/2022] [Revised: 11/29/2022] [Accepted: 12/02/2022] [Indexed: 06/17/2023]
Abstract
The emerging and re-emerging vector-borne diseases transmitted by key freshwater organisms have remained a global concern. As one of the leading biodiversity hotspots, the African ecoregion is suggested to harbour the highest number of freshwater organisms globally. Among the commonly found organisms in the African ecoregion are mosquitoes and snails, with a majority of their life cycle in freshwater, and these freshwater organisms can transmit diseases or serve as carriers of devastating diseases of public health concerns. However, synthetic studies to link the evident abundant presence and wide distribution of these vectors across the freshwater ecosystems in Africa with the increasing emerging and re-emerging vector-borne diseases in Africa are still limited. Here, we reviewed documented evidence on vector-borne diseases and their transmission pathways in Africa to reduce the knowledge gap on the factors influencing the increasing emerging and re-emerging vector-borne diseases across Africa. We found the population distributions or abundance of these freshwater organisms to be increasing, which is directly associated with the increasing emerging and re-emerging vector-borne diseases across Africa. Furthermore, we found that although the current changing environmental conditions in Africa affect the habitats of these freshwater organisms, current changing environmental conditions may not be suppressing the population distributions or abundance of these freshwater organisms. Instead, we found that these freshwater organisms are extending their geographic ranges across Africa, which may have significant public health implications in Africa. Thus, our study demonstrates the need for future studies to integrate the environmental conditions of vectors' habitats to understand if these environmental conditions directly or indirectly influence the vectorial capacities and transmission abilities of vectors of diseases. We propose that such studies will be necessary to guide policymakers in making informed policies to help control vector-borne diseases.
Collapse
Affiliation(s)
- Onyekwere Joseph Okoro
- Department of Zoology and Environmental Biology, Faculty of Biological Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria; Organization of African Academic Doctors (OAAD), P.O. Box 14833-00100, Langata, Nairobi, Kenya
| | - Gideon Gywa Deme
- Department of Biology, Case Western Reserve University, Cleveland, OH 44106, USA; Organization of African Academic Doctors (OAAD), P.O. Box 14833-00100, Langata, Nairobi, Kenya.
| | - Charles Obinwanne Okoye
- Department of Zoology and Environmental Biology, Faculty of Biological Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria; Biofuels Institute, School of Environment and Safety Engineering, Jiangsu University, Zhenjiang 212013, China; Organization of African Academic Doctors (OAAD), P.O. Box 14833-00100, Langata, Nairobi, Kenya
| | - Sabina Chioma Eze
- Department of Biological Sciences, Faculty of Science, Federal University of Health Sciences, Otukpo 972221, Benue State, Nigeria; Organization of African Academic Doctors (OAAD), P.O. Box 14833-00100, Langata, Nairobi, Kenya
| | - Elijah Chibueze Odii
- Department of Zoology and Environmental Biology, Faculty of Biological Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria; Organization of African Academic Doctors (OAAD), P.O. Box 14833-00100, Langata, Nairobi, Kenya
| | - Janet Temitope Gbadegesin
- School of Public Health, University of the Western Cape, South Africa; Organization of African Academic Doctors (OAAD), P.O. Box 14833-00100, Langata, Nairobi, Kenya
| | - Emmanuel Sunday Okeke
- Department of Biochemistry, Faculty of Biological Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria; Natural Science Unit, School of General Studies, University of Nigeria, Nsukka 410001, Enugu State, Nigeria; Institute of Environmental Health and Ecological Security, School of Environment and Safety Engineering, Jiangsu University, Zhenjiang 212013, China; Organization of African Academic Doctors (OAAD), P.O. Box 14833-00100, Langata, Nairobi, Kenya
| | - Greater Kayode Oyejobi
- Key Laboratory of Special Pathogens and Biosafety, Centre for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, Hubei, China; Department of Microbiology, Faculty of Basic and Applied Sciences, Osun State University, Osogbo 230212, Osun State, Nigeria; Organization of African Academic Doctors (OAAD), P.O. Box 14833-00100, Langata, Nairobi, Kenya; School of Pharmaceutical Sciences, Wuhan University, Hubei, P.R. China. 430072
| | - Raphael Nyaruaba
- Key Laboratory of Special Pathogens and Biosafety, Centre for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, Hubei, China; Organization of African Academic Doctors (OAAD), P.O. Box 14833-00100, Langata, Nairobi, Kenya
| | - Chike Chukwuenyem Ebido
- Department of Zoology and Environmental Biology, Faculty of Biological Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria; Organization of African Academic Doctors (OAAD), P.O. Box 14833-00100, Langata, Nairobi, Kenya.
| |
Collapse
|
|
10
|
Zerfu B, Kassa T, Legesse M. Epidemiology, biology, pathogenesis, clinical manifestations, and diagnosis of dengue virus infection, and its trend in Ethiopia: a comprehensive literature review. Trop Med Health 2023; 51:11. [PMID: 36829222 PMCID: PMC9950709 DOI: 10.1186/s41182-023-00504-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2022] [Accepted: 02/15/2023] [Indexed: 02/26/2023] Open
Abstract
Dengue fever is a dengue virus infection, emerging rapidly and posing public health threat worldwide, primarily in tropical and subtropical countries. Nearly half of the world's population is now at risk of contracting the dengue virus, including new countries with no previous history-like Ethiopia. However, little is known about the epidemiology and impact of the disease in different countries. This is especially true in countries, where cases have recently begun to be reported. This review aims to summarize epidemiology, biology, pathogenesis, clinical manifestations, and diagnosis of dengue virus infection and its trend in Ethiopia. It may help countries, where dengue fever is not yet on the public health list-like Ethiopia to alert healthcare workers to consider the disease for diagnosis and treatment. The review retrieved and incorporated 139 published and organizational reports showing approximately 390 million new infections. About 100 million of these infections develop the clinical features of dengue, and thousands of people die annually from severe dengue fever in 129 countries. It is caused by being bitten by a dengue virus-infected female mosquito, primarily Aedes aegypti and, lesser, Ae. albopictus. Dengue virus is a member of the Flavivirus genus of the Flaviviridae family and has four independent but antigen-related single-stranded positive-sense RNA virus serotypes. The infection is usually asymptomatic but causes illnesses ranging from mild febrile illness to fatal dengue hemorrhagic fever or shock syndrome. Diagnosis can be by detecting the virus genome using nucleic acids amplification tests or testing NS1 antigen and/or anti-dengue antibodies from serum, plasma, circulating blood cells, or other tissues. Dengue cases and outbreaks have increased in recent decades, with a significant public health impact. Ethiopia has had nearly annual outbreaks since 2013, devastating an already fragmented health system and economy. Standardization of medication, population-level screening for early diagnosis and prompt treatment, and minimization of mosquito bites reduce overall infection and mortality rates.
Collapse
Affiliation(s)
- Biruk Zerfu
- Department of Medical Laboratory Science, College of Health Science, Addis Ababa University, Addis Ababa, Ethiopia. .,Aklilu Lema Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
| | - Tesfu Kassa
- grid.7123.70000 0001 1250 5688Aklilu Lema Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia
| | - Mengistu Legesse
- grid.7123.70000 0001 1250 5688Aklilu Lema Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia
| |
Collapse
|
|
11
|
Kassam NA, Laswai D, Kulaya N, Kaaya RD, Kajeguka DC, Schmiegelow C, Wang CW, Alifrangis M, Kavishe RA. Human IgG responses to Aedes mosquito salivary peptide Nterm-34kDa and its comparison to Anopheles salivary antigen (gSG6-P1) IgG responses measured among individuals living in Lower Moshi, Tanzania. PLoS One 2022; 17:e0276437. [PMID: 36301860 PMCID: PMC9612500 DOI: 10.1371/journal.pone.0276437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Accepted: 09/13/2022] [Indexed: 01/24/2023] Open
Abstract
BACKGROUND The level of human exposure to arbovirus vectors, the Aedes mosquitoes, is mainly assessed by entomological methods which are labour intensive, difficult to sustain at a large scale and are affected if transmission and exposure levels are low. Alternatively, serological biomarkers which detect levels of human exposure to mosquito bites may complement the existing epidemiologic tools as they seem cost-effective, simple, rapid, and sensitive. This study explored human IgG responses to an Aedes mosquito salivary gland peptide Nterm-34kDa in Lower Moshi, a highland area with evidence of circulating arboviruses and compared the Aedes IgG responses to Anopheles mosquitoes' salivary antigen (GSG6-P1) IgG responses. METHODS Three cross-sectional surveys were conducted in 2019: during the first dry season in March, at the end of the rainy season in June and during the second dry season in September in five villages located in Lower Moshi. Blood samples were collected from enrolled participants above six months of age (age span: 7 months to 94 years) and analysed for the presence of anti-Nterm-34kDa IgG antibodies. Possible associations between Nterm-34kDa seroprevalence and participants' characteristics were determined. Levels of IgG responses and seroprevalence were correlated and compared to the already measured IgG responses and seroprevalence of Anopheles mosquitoes' salivary antigen, GSG6-P1. RESULTS During the first dry season, Nterm-34kDa seroprevalence was 34.1% and significantly increased at the end of the rainy season to 45.3% (Chi square (χ2) = 6.42 p = 0.011). During the second dry season, the seroprevalence significantly declined to 26.5% (χ2 = 15.12 p<0.001). During the rainy season, seroprevalence was significantly higher among residents of Oria village (adjusted odds ratio (AOR) = 2.86; 95% CI = 1.0-7.8; p = 0.041) compared to Newland. Moreover, during the rainy season, the risk of exposure was significantly lower among individuals aged between 16 and 30 years (AOR = 0.25; 95% CI = 0.1 = 0.9; p = 0.036) compared to individuals aged between 0 and 5 years. There was weak to moderate negative correlation between N-term 34kDa IgG and gSG6-P1 antigens. N-term 34kDa seroprevalence were higher compared to gSG6-P1 seroprevalence. CONCLUSION The findings of this study support that IgG antibody responses towards the Aedes mosquito salivary peptide Nterm-34kDa are detectable among individuals living in lower Moshi and vary with season and geographical area. More individuals are exposed to Aedes mosquito bites than Anopheles mosquito and those exposed to Aedes bites are not necessarily exposed to Anopheles mosquitoes.
Collapse
Affiliation(s)
- Nancy A. Kassam
- Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania
- * E-mail:
| | - Daniel Laswai
- Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania
| | - Neema Kulaya
- Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania
| | - Robert D. Kaaya
- Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania
- Pan-African Malaria Vector Research Consortium, Moshi, Tanzania
| | - Debora C. Kajeguka
- Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania
| | - Christentze Schmiegelow
- Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
| | - Christian W. Wang
- Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
| | - Michael Alifrangis
- Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen and Department of Infectious Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
| | | |
Collapse
|
|
12
|
Manabe YC, Betz J, Jackson O, Asoala V, Bazan I, Blair PW, Chang A, Chusri S, Crump JA, Edgel KA, Faix DJ, Fernandez S, Fox AT, Garcia JA, Grogl M, Hansen EA, Heang V, House SL, Jongsakul K, Kaburise MB, Klungthong C, Lamorde M, Letizia AG, Lorenzana I, Luy M, Maro VP, Mores CN, Myers CA, Oduro AR, Parham L, Porzucek AJ, Prouty M, Rabiger DS, Rubach MP, Siles C, Silva M, Ukachu C, Waitumbi JN, Phillips CL, Jones BW. Clinical evaluation of the BioFire Global Fever Panel for the identification of malaria, leptospirosis, chikungunya, and dengue from whole blood: a prospective, multicentre, cross-sectional diagnostic accuracy study. THE LANCET. INFECTIOUS DISEASES 2022; 22:1356-1364. [PMID: 35716700 PMCID: PMC9420791 DOI: 10.1016/s1473-3099(22)00290-0] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/01/2022] [Revised: 03/27/2022] [Accepted: 04/12/2022] [Indexed: 12/29/2022]
Abstract
BACKGROUND Acute febrile illness is a common presentation for patients at hospitals globally. Assays that can diagnose a variety of common pathogens in blood could help to establish a diagnosis for targeted disease management. We aimed to evaluate the performance of the BioFire Global Fever Panel (GF Panel), a multiplex nucleic acid amplification test performed on whole blood specimens run on the BioFire FilmArray System, in the diagnosis of several pathogens that cause acute febrile illness. METHODS We did a prospective, multicentre, cross-sectional diagnostic accuracy study to evaluate the GF Panel. Consenting adults and children older than 6 months presenting with fever in the previous 2 days were enrolled consecutively in sub-Saharan Africa (Ghana, Kenya, Tanzania, Uganda), southeast Asia (Cambodia, Thailand), central and South America (Honduras, Peru), and the USA (Washington, DC; St Louis, MO). We assessed the performance of six analytes (chikungunya virus, dengue virus [serotypes 1-4], Leptospira spp, Plasmodium spp, Plasmodium falciparum, and Plasmodium vivax or Plasmodium ovale) on the GF Panel. The performance of the GF Panel was assessed using comparator PCR assays with different primers followed by bidirectional sequencing on nucleic acid extracts from the same specimen. We calculated the positive percent agreement and negative percent agreement of the GF Panel with respect to the comparator assays. This study is registered with ClinicalTrials.gov, NCT02968355. FINDINGS From March 26, 2018, to Sept 30, 2019, 1965 participants were enrolled at ten sites worldwide. Of the 1875 participants with analysable results, 980 (52·3%) were female and the median age was 22 years (range 0-100). At least one analyte was detected in 657 (35·0%) of 1875 specimens. The GF Panel had a positive percent agreement for the six analytes evaluated as follows: chikungunya virus 100% (95% CI 86·3-100), dengue virus 94·0% (90·6-96·5), Leptospira spp 93·8% (69·8-99·8), Plasmodium spp 98·3% (96·3-99·4), P falciparum 92·7% (88·8-95·6), and P vivax or P ovale 92·7% (86·7-96·6). The GF Panel had a negative percent agreement equal to or greater than 99·2% (98·6-99·6) for all analytes. INTERPRETATION This 1 h sample-to-answer, molecular device can detect common causative agents of acute febrile illness with excellent positive percent agreement and negative percent agreement directly in whole blood. The targets of the assay are prevalent in tropical and subtropical regions globally, and the assay could help to provide both public health surveillance and individual diagnoses. FUNDING BioFire Defense, Joint Project Manager for Medical Countermeasure Systems and US Army Medical Materiel Development Activity, and National Institute of Allergy and Infectious Diseases.
Collapse
Affiliation(s)
- Yukari C Manabe
- Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
| | - Joshua Betz
- Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
| | | | - Victor Asoala
- Navrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana
| | - Isabel Bazan
- Virology and Emerging Infections Department, US Naval Medical Research Unit Six, Lima, Peru
| | - Paul W Blair
- Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Aileen Chang
- Department of Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC, USA
| | - Sarunyou Chusri
- Faculty of Medicine, Prince of Songkhla University, Songkhla, Thailand
| | - John A Crump
- Division of Infectious Diseases & International Health, Department of Medicine, Duke University, Durham, NC, USA; Centre for International Health, University of Otago, Dunedin, New Zealand
| | | | - Dennis J Faix
- US Naval Medical Research Unit Two, Phnom Penh, Cambodia
| | - Stefan Fernandez
- Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
| | - Anne T Fox
- US Naval Medical Research Unit Three, Ghana Detachment, Accra, Ghana
| | - Jose A Garcia
- US Naval Medical Research Unit Two, Phnom Penh, Cambodia
| | - Max Grogl
- Virology and Emerging Infections Department, US Naval Medical Research Unit Six, Lima, Peru
| | - Erin A Hansen
- Operational Infectious Diseases, Naval Health Research Center, San Diego, CA, USA
| | - Vireak Heang
- US Naval Medical Research Unit Two, Phnom Penh, Cambodia
| | - Stacey L House
- Washington University School of Medicine, Department of Emergency Medicine, St Louis, MO, USA
| | - Krisada Jongsakul
- Department of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
| | | | - Chonticha Klungthong
- Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
| | - Mohammed Lamorde
- Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda
| | - Andrew G Letizia
- US Naval Medical Research Unit Three, Ghana Detachment, Accra, Ghana
| | - Ivette Lorenzana
- Universidad Nacional Autónoma de Honduras, Centro de Investigaciones Geneticas, Instituto de Investigacion en Microdbiologia, Tegucigalpa, Honduras
| | - Malen Luy
- US Naval Medical Research Unit Two, Phnom Penh, Cambodia
| | - Vanance P Maro
- Department of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania
| | - Christopher N Mores
- Virology and Emerging Infections Department, US Naval Medical Research Unit Six, Lima, Peru; Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA
| | - Christopher A Myers
- Operational Infectious Diseases, Naval Health Research Center, San Diego, CA, USA
| | - Abraham R Oduro
- Navrongo Health Research Centre, Ghana Health Service, Navrongo, Ghana
| | - Leda Parham
- Universidad Nacional Autónoma de Honduras, Centro de Investigaciones Geneticas, Instituto de Investigacion en Microdbiologia, Tegucigalpa, Honduras
| | - Abigail J Porzucek
- Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA
| | - Michael Prouty
- Virology and Emerging Infections Department, US Naval Medical Research Unit Six, Lima, Peru
| | | | - Matthew P Rubach
- Division of Infectious Diseases & International Health, Department of Medicine, Duke University, Durham, NC, USA
| | - Crystyan Siles
- Virology and Emerging Infections Department, US Naval Medical Research Unit Six, Lima, Peru
| | - Maria Silva
- Virology and Emerging Infections Department, US Naval Medical Research Unit Six, Lima, Peru
| | - Chinaka Ukachu
- Operational Infectious Diseases, Naval Health Research Center, San Diego, CA, USA
| | - John N Waitumbi
- US Army Medical Research Directorate-Africa, Kenya Medical Research Institute, Nairobi, Kenya
| | | | | |
Collapse
|
|
13
|
Letizia AG, Pratt CB, Wiley MR, Fox AT, Mosore M, Agbodzi B, Yeboah C, Kumordjie S, Di Paola N, Assana KC, Coulidiaty D, Ouedraogo C, Bonney JHK, Ampofo W, Tarnagda Z, Sangaré L. Retrospective Genomic Characterization of a 2017 Dengue Virus Outbreak, Burkina Faso. Emerg Infect Dis 2022; 28:1198-1210. [PMID: 35608626 PMCID: PMC9155902 DOI: 10.3201/eid2806.212491] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Knowledge of contemporary genetic composition of dengue virus (DENV) in Africa is lacking. By using next-generation sequencing of samples from the 2017 DENV outbreak in Burkina Faso, we isolated 29 DENV genomes (5 serotype 1, 16 serotype 2 [DENV-2], and 8 serotype 3). Phylogenetic analysis demonstrated the endemic nature of DENV-2 in Burkina Faso. We noted discordant diagnostic results, probably related to genetic divergence between these genomes and the Trioplex PCR. Forward and reverse1 primers had a single mismatch when mapped to the DENV-2 genomes, probably explaining the insensitivity of the molecular test. Although we observed considerable homogeneity between the Dengvaxia and TetraVax-DV-TV003 vaccine strains as well as B cell epitopes compared with these genomes, we noted unique divergence. Continual surveillance of dengue virus in Africa is needed to clarify the ongoing novel evolutionary dynamics of circulating virus populations and support the development of effective diagnostic, therapeutic, and preventive countermeasures.
Collapse
|
|
14
|
Wu Q, Dong S, Li X, Yi B, Hu H, Guo Z, Lu J. Effects of COVID-19 Non-Pharmacological Interventions on Dengue Infection: A Systematic Review and Meta-Analysis. Front Cell Infect Microbiol 2022; 12:892508. [PMID: 35663468 PMCID: PMC9162155 DOI: 10.3389/fcimb.2022.892508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2022] [Accepted: 04/19/2022] [Indexed: 11/30/2022] Open
Abstract
Non-pharmacological interventions (NPIs) implemented during the coronavirus disease 2019 (COVID-19) pandemic have demonstrated significant positive effects on other communicable diseases. Nevertheless, the response for dengue fever has been mixed. To illustrate the real implications of NPIs on dengue transmission and to determine the effective measures for preventing and controlling dengue, we performed a systematic review and meta-analysis of the available global data to summarize the effects comprehensively. We searched Embase, PubMed, and Web of Science in line with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines from December 31, 2019, to March 30, 2022, for studies of NPI efficacy on dengue infection. We obtained the annual reported dengue cases from highly dengue-endemic countries in 2015–2021 from the European Centre for Disease Prevention and Control to determine the actual change in dengue cases in 2020 and 2021, respectively. A random-effects estimate of the pooled odds was generated with the Mantel-Haenszel method. Between-study heterogeneity was assessed using the inconsistency index (I2) and subgroup analysis according to country (dengue-endemic or non-endemic) was conducted. This review was registered with PROSPERO (CRD42021291487). A total of 17 articles covering 32 countries or regions were included in the review. Meta-analysis estimated a pooled relative risk of 0.39 (95% CI: 0.28–0.55), and subgroup revealed 0.06 (95% CI: 0.02-0.25) and 0.55 (95% CI: 0.44-0.68) in dengue non-endemic areas and dengue-endemic countries, respectively, in 2020. The majority of highly dengue-endemic countries in Asia and Americas reported 0–100% reductions in dengue cases in 2020 compared to previous years, while some countries (4/20) reported a dramatic increase, resulting in an overall increase of 11%. In contrast, there was an obvious reduction in dengue cases in 2021 in almost all countries (18/20) studied, with an overall 40% reduction rate. The overall effectiveness of NPIs on dengue varied with region and time due to multiple factors, but most countries reported significant reductions. Travel-related interventions demonstrated great effectiveness for reducing imported cases of dengue fever. Internal movement restrictions of constantly varying intensity and range are more likely to mitigate the entire level of dengue transmission by reducing the spread of dengue fever between regions within a country, which is useful for developing a more comprehensive and sustainable strategy for preventing and controlling dengue fever in the future.
Collapse
Affiliation(s)
- Qin Wu
- One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, China
- National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, China
| | - Shuwen Dong
- One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, China
- National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, China
| | - Xiaokang Li
- One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, China
- National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, China
| | - Boyang Yi
- One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, China
- National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, China
| | - Huan Hu
- One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, China
- National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, China
| | - Zhongmin Guo
- Sun Yat-Sen College of Medical Science, Sun Yat-sen University, Guangzhou, China
- *Correspondence: Jiahai Lu, ; Zhongmin Guo,
| | - Jiahai Lu
- One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, China
- National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, China
- Research Institute of Sun Yat-Sen University in Shenzhen, Shenzhen, China
- Hainan Medical University ' One Health' " Research Center, Hainan Medical University, Hainan, China
- *Correspondence: Jiahai Lu, ; Zhongmin Guo,
| |
Collapse
|
|
15
|
Mukhtar MM, Ibrahim SS. Temporal Evaluation of Insecticide Resistance in Populations of the Major Arboviral Vector Aedes Aegypti from Northern Nigeria. INSECTS 2022; 13:187. [PMID: 35206760 PMCID: PMC8876019 DOI: 10.3390/insects13020187] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Revised: 02/02/2022] [Accepted: 02/08/2022] [Indexed: 11/24/2022]
Abstract
To support evidence-based control measures, two Nigerian Aedes populations (BUK and Pantami) were characterised. Larval bioassay using temephos and deltamethrin revealed a significant increase in deltamethrin resistance, with LC50 of 0.018mg/L (resistance ratio compared to New Orleans, RR = 2.250) in 2018 increasing ~6-fold, by 2019 (LC50 = 0.100mg/L, RR = 12.5), and ~11-fold in 2020 (LC50 = 0.198mg/L, RR = 24.750). For the median deltamethrin concentration (0.05mg/L), a gradual decrease in mortality was observed, from 50.6% in 2018, to 44.9% in 2019, and 34.2% in 2020. Extremely high DDT resistance was observed, with <3% mortalities and LT50s of 352.87 min, 369.19 min and 406.94 min in 2018, 2019 and 2020, respectively. Significant temporal increase in resistance was observed towards ƛ-cyhalothrin (a type II pyrethroid) over three years. Synergist bioassays with diethylmaleate and piperonylbutoxide significantly recovered DDT and ƛ-cyhalothrin susceptibility respectively, implicating glutathione S-transferases and CYP450s. Cone bioassays revealed increased resistance to the PermaNet® 3.0, side panels (mortalities of 94% in 2018, 66.4% in 2019, and 73.6% in 2020), while full susceptibility was obtained with the roof of PermaNet® 3.0. The F1534C kdr mutation occurred in low frequency, with significant correlation between heterozygote genotypes and DDT resistance. This temporal increase in resistance is a major challenge for control of this vector of public health importance.
Collapse
|